does glp 1 slow gastric emptying GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Glucagon Like Peptide 1 -

For best results, add lifestyle habits that naturally support growth hormone productionthink quality sleep, resistance training, and balanced nutrition

Glutathione has also emerged a key modulator of xenobiotic toxicity, most notably the persistent organic pollutants which are associated with many diseases of impaired metabolic activity, including diabetes, obesity, and cardiovascular disease

Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits

Today I offer a brief glimpse of seven reports in the past six months on eye problems associated with - but not proven to be caused by - the use of GLP-1 drugs